Literature DB >> 2163119

Glycine site associated with the NMDA receptor modulates long-term potentiation.

M W Oliver1, M Kessler, J Larson, F Schottler, G Lynch.   

Abstract

Recent work has shown that kynurenic acid and several quinoxaline derivatives act as non-competitive NMDA receptor antagonists by binding to the glycine site associated with this receptor. In this study, we have tested the effect of the most potent and selective of these compounds, 7-chlorokynurenic acid (Cl-Kyn), on the induction of long-term potentiation, an event known to involve activation of NMDA receptors. It was found that 30 microM Cl-Kyn reversibly abolished the development of both short-term and long-term potentiation in the CA1 region of hippocampal slices. The effectiveness of Cl-Kyn matched its ability to inhibit 3H-glycine binding and the association of 3H-TCP with the NMDA receptor in binding experiments (Ki 0.7-1 microM). Weak interactions of Cl-Kyn with AMPA receptor sites were observed and may account for a partial, reversible reduction in the epsp. However, blockade of long-term potentiation by Cl-Kyn was completely reversed by simultaneous application of the glycine site agonist D-serine and thus must be attributed to its interaction with the glycine site. These results indicate that the glycine site coupled to the NMDA receptor potently modulates channel function during physiological events related to synaptic activation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2163119     DOI: 10.1002/syn.890050403

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  5 in total

Review 1.  Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders.

Authors:  Sophie Erhardt; Sara K Olsson; Göran Engberg
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

2.  D-Cycloserine: Agonist turned antagonist.

Authors:  T H Lanthorn
Journal:  Amino Acids       Date:  1994-10       Impact factor: 3.520

3.  D-serine increases adult hippocampal neurogenesis.

Authors:  Sebastien Sultan; Elias G Gebara; Kristell Moullec; Nicolas Toni
Journal:  Front Neurosci       Date:  2013-08-29       Impact factor: 4.677

Review 4.  Pharmacological enhancement of memory or cognition in normal subjects.

Authors:  Gary Lynch; Conor D Cox; Christine M Gall
Journal:  Front Syst Neurosci       Date:  2014-05-20

Review 5.  Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives.

Authors:  Tamás Biernacki; Dániel Sandi; Krisztina Bencsik; László Vécsei
Journal:  Cells       Date:  2020-06-26       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.